![New Insights on Vitamin C and Cancer (SpringerBriefs in Cancer Research) 2014, Gonzalez, Michael J., Miranda-Massari, Jorge R. - Amazon.com New Insights on Vitamin C and Cancer (SpringerBriefs in Cancer Research) 2014, Gonzalez, Michael J., Miranda-Massari, Jorge R. - Amazon.com](https://m.media-amazon.com/images/I/51dfp-ajhvL.jpg)
New Insights on Vitamin C and Cancer (SpringerBriefs in Cancer Research) 2014, Gonzalez, Michael J., Miranda-Massari, Jorge R. - Amazon.com
![High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer | Journal of Experimental & Clinical Cancer Research | Full Text High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer | Journal of Experimental & Clinical Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13046-021-02134-y/MediaObjects/13046_2021_2134_Fig6_HTML.png)
High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer | Journal of Experimental & Clinical Cancer Research | Full Text
![Frontiers | Intravenous Vitamin C for Cancer Therapy – Identifying the Current Gaps in Our Knowledge Frontiers | Intravenous Vitamin C for Cancer Therapy – Identifying the Current Gaps in Our Knowledge](https://www.frontiersin.org/files/Articles/391115/fphys-09-01182-HTML/image_m/fphys-09-01182-g001.jpg)
Frontiers | Intravenous Vitamin C for Cancer Therapy – Identifying the Current Gaps in Our Knowledge
![PDF] Evidence-based complementary treatment of pancreatic cancer: a review of adjunct therapies including paricalcitol, hydroxychloroquine, intravenous vitamin C, statins, metformin, curcumin, and aspirin | Semantic Scholar PDF] Evidence-based complementary treatment of pancreatic cancer: a review of adjunct therapies including paricalcitol, hydroxychloroquine, intravenous vitamin C, statins, metformin, curcumin, and aspirin | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/58fac5c3602f566c6b965ec4401d8341ee1ad0ca/5-Figure2-1.png)
PDF] Evidence-based complementary treatment of pancreatic cancer: a review of adjunct therapies including paricalcitol, hydroxychloroquine, intravenous vitamin C, statins, metformin, curcumin, and aspirin | Semantic Scholar
![High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer | Journal of Experimental & Clinical Cancer Research | Full Text High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer | Journal of Experimental & Clinical Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13046-021-02134-y/MediaObjects/13046_2021_2134_Fig3_HTML.png)
High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer | Journal of Experimental & Clinical Cancer Research | Full Text
![PDF] Evidence-based complementary treatment of pancreatic cancer: a review of adjunct therapies including paricalcitol, hydroxychloroquine, intravenous vitamin C, statins, metformin, curcumin, and aspirin | Semantic Scholar PDF] Evidence-based complementary treatment of pancreatic cancer: a review of adjunct therapies including paricalcitol, hydroxychloroquine, intravenous vitamin C, statins, metformin, curcumin, and aspirin | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/58fac5c3602f566c6b965ec4401d8341ee1ad0ca/4-Figure1-1.png)